Governance
Medical Review Process
Medical, dosing, safety, pharmacology, and research pages are reviewed by a named clinician whose National Provider Identifier has been verified against the public CMS NPPES registry. Review checks that language matches FDA labelling and the primary literature, that trial results are not overstated, and that no individualised clinical instruction appears.
Key takeaways
- Medical, dosing, safety, and research content requires review by a named, NPI-verified clinician.
- Reviewers verify language against FDA labelling and primary literature, not against marketing copy.
- Review confirms accuracy; it does not create a clinician-patient relationship or constitute medical advice.
- A separate medically reviewed date is stored and displayed, and changes only on substantive re-review.
- Re-review is triggered by label changes, new trial results, regulatory action, or a reported error.
| Reviewers | Jonathan Snipes, MD · Kim Callender, NP, FNP-BC |
|---|---|
| Credential verification | NPI checked against the public CMS NPPES registry |
| Content requiring review | Medical, dosing, safety, pharmacology, research |
| Displayed date | Medically reviewed — shown on every reviewed page |
| Re-review triggers | Label change, new trial data, regulatory action, reported error |
What does a reviewer actually check?
Whether each clinical statement matches current FDA labelling and the primary literature; whether trial results are described with their real population, dose, and duration rather than generalised; whether compounded products are anywhere implied to share the approved product's evidence; and whether any sentence has drifted into individualised clinical instruction.
What does medical review not mean?
It does not mean the reviewer is your clinician, that the content is personalised to you, or that the publication can advise on your treatment. Review is a quality control on published language. Decisions about your care require a prescriber who knows your history.
What triggers a re-review?
- A change to FDA labelling for tirzepatide or a comparator.
- Publication of new randomised trial data affecting a stated conclusion.
- Regulatory or enforcement action relevant to compounded products.
- A reported factual error accepted under the corrections policy.
- Annual scheduled re-review of medical guides.
How much of this site's data is actually verified?
| Group | Records |
|---|---|
| Trials with full identifiers | 8 |
| Trials partially verified | 1 |
| Trials withheld pending audit | 1 |
| Providers with verified all-in price | 5 |
| Providers excluded with reason | 19 |
| Evidence status | Definition | What may be published |
|---|---|---|
| Verified | Checked against a primary source with a recorded date | The claim, with its identifier and date |
| Partially verified | Some elements confirmed, others outstanding | Confirmed elements only; the rest labelled |
| Verification Pending | Not yet checked against a primary source | No factual assertion — the gap is shown |
What does this page cover, and what does it deliberately leave out?
This page addresses Reviewer credentials, scope, dates and re-review triggers, organised around the primary question of tirzepatide medical review process. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.
| Element | Treatment here | Evidence basis |
|---|---|---|
| Reviewer credentials | Covered on this page | Regulatory or policy source |
| Scope | Covered on this page | Regulatory or policy source |
| Dates | Covered on this page | Regulatory or policy source |
| Re-review triggers | Covered on this page | Regulatory or policy source |
| Individualized clinical instruction | Deliberately not covered | Belongs with the corrections process |
What are the limits of what this page can tell you?
Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
This page would be revised, with the change recorded in its history, if any of the following occurred:
- New primary evidence bearing directly on tirzepatide medical review process.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
Frequently asked questions
Who reviews the medical content?
Named clinicians with NPI records verified against the CMS NPPES registry.
Is reviewed content medical advice?
No. Review is quality control on published language and creates no clinician-patient relationship.
When is content re-reviewed?
On label changes, new trial data, regulatory action, reported errors, and at least annually.
Why do some pages have no medical reviewer?
Because they are not medical content — policy, methodology, and data pages are reviewed editorially.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.